Detalles de la búsqueda
1.
Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project.
Cancer Control
; 28: 10732748211009256, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33874754
2.
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
Clin Med Insights Oncol
; 10: 95-104, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27721664
Resultados
1 -
2
de 2
1
Próxima >
>>